Koesten Hirschmann & Crabtree’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-174
Closed -$1.73K 235
2025
Q3
$1.73K Buy
174
+2
+1% +$19 ﹤0.01% 196
2025
Q2
$1.54K Buy
172
+2
+1% +$17 ﹤0.01% 242
2025
Q1
$1.48K Buy
170
+2
+1% +$21 ﹤0.01% 174
2024
Q4
$2.09K Buy
168
+2
+1% +$25 ﹤0.01% 155
2024
Q3
$1.93K Buy
166
+3
+2% +$35 ﹤0.01% 157
2024
Q2
$1.94K Hold
163
﹤0.01% 178
2024
Q1
$1.94K Buy
163
+2
+1% +$24 ﹤0.01% 178
2023
Q4
$1.74K Buy
161
+2
+1% +$19 ﹤0.01% 150
2023
Q3
$1.57K Buy
159
+2
+1% +$21 ﹤0.01% 146
2023
Q2
$1.57K Buy
157
+2
+1% +$19 ﹤0.01% 136
2023
Q1
$1.5K Buy
155
+2
+1% +$22 ﹤0.01% 170
2022
Q4
$1.71K Buy
+153
New +$1.6K ﹤0.01% 137

Other funds holding VTRS

Koesten Hirschmann & Crabtree's VTRS Position: Q4 2025 in Review

Koesten Hirschmann & Crabtree sold out of Viatris (VTRS) in Q4 2025, closing a stake of 174 shares — an estimated $1.73K sold.

Koesten Hirschmann & Crabtree first reported a position in VTRS in Q4 2022 and held it in 12 quarters. The position peaked at $2.09K in Q4 2024. 1,010 funds tracked by Wall St. Rank hold VTRS as of Q4 2025.

  • Koesten Hirschmann & Crabtree reported no remaining Viatris position as of Q4 2025 after selling out during the quarter.
  • Koesten Hirschmann & Crabtree sold 174 Viatris shares in Q4 2025, an estimated $1.73K.
  • Koesten Hirschmann & Crabtree first reported a position in Viatris in Q4 2022 and held it in 12 quarters.
  • Koesten Hirschmann & Crabtree's Viatris position peaked at $2.09K in Q4 2024.
  • 1,010 funds tracked by Wall St. Rank held Viatris as of Q4 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q4 2025, filed 9 Feb 2026.